-
Multivalent CXCR4-targeting nanobody formats differently affect affinity, receptor clustering, and antagonism
Anbuhl, S. M., Dervillez, X., Neubacher, S., Bobkov, V., de Taeye, S. W., Szpakowska, M., Siderius, M., Grossmann, T. N., Chevigné, A., Smit, M. J. & Heukers, R., 1 Sept 2024, In: Biochemical Pharmacology. 227, 116457.Research output: Contribution to journal › Article › Academic › peer-review
-
Differences in IgG autoantibody Fab glycosylation across autoimmune diseases
T2B Consortium, Jun 2023, In: Journal of allergy and clinical immunology. 151, 6, p. 1646-1654 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions (Front. Immunol., (2022), 13, 893648, 10.3389/fimmu.2022.893648)
van Haaren, M. M., Dekkers, G., Bentlage, A. E. H., Grobben, M., Sanders, R. W., Geijtenbeek, T. B. H., Heukers, R., Kootstra, N. A., de Taeye, S. W. & van Gils, M. J., 22 Nov 2022, In: Frontiers in immunology. 13, 1091668.Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications